TELA Bio, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TELA Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- TELA Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $6.00K, a 89.29% decline year-over-year.
- TELA Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-12-31 was $26.00K, a 333.33% increase year-over-year.
- TELA Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $1.00K, a 0.00% change year-over-year.
- TELA Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $127.00K, a 568.42% increase from fiscal 2022.
- TELA Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $19.00K, a 96.53% decline from fiscal 2021.
- TELA Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $547.00K, a 212.57% increase from fiscal 2020.
- TELA Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $175.00K, a 1150.00% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | |
| 2024-06-30 | $6.00K 10-Q · filed 2025-08-11 | |
| 2023-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $127.00K 10-K · filed 2024-03-22 |
| 2023-09-30 | $1.00K 10-Q · filed 2023-11-13 | $107.00K derived: sum of 4 quarters · filed 2024-03-22 |
| 2023-06-30 | $56.00K 10-Q · filed 2023-08-10 | $107.00K derived: sum of 4 quarters · filed 2024-03-22 |
| 2023-03-31 | $44.00K 10-Q · filed 2023-05-11 | $56.00K derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $19.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $1.00K 10-Q · filed 2023-11-13 | $149.00K derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | $5.00K 10-Q · filed 2023-08-10 | $407.00K derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | $7.00K 10-Q · filed 2023-05-11 | $518.00K derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | $136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $547.00K 10-K · filed 2024-03-22 |
| 2021-09-30 | $259.00K 10-Q · filed 2022-11-10 | $423.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $116.00K 10-Q · filed 2022-08-11 | $283.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | $36.00K 10-Q · filed 2022-05-11 | $203.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $175.00K 10-K · filed 2023-03-23 |
| 2020-09-30 | $119.00K 10-Q · filed 2021-11-12 | $165.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | $36.00K 10-Q · filed 2021-08-12 | $50.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | $8.00K 10-Q · filed 2021-05-14 | $19.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2019-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $14.00K 10-K · filed 2022-03-23 |
| 2019-09-30 | $4.00K 10-Q · filed 2020-11-12 | $11.00K derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | $5.00K 10-Q · filed 2020-08-13 | $8.00K derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-03-31 | $3.00K 10-Q · filed 2020-05-15 | |
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $5.00K 10-K · filed 2021-03-25 |
| 2018-09-30 | $1.00K 10-Q · filed 2019-12-18 | |
| 2017-12-31 | $2.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |